Cargando…
Disinfectants In Interventional Practices
PURPOSE OF REVIEW: This review aims to provide relevant, aggregate information about a variety of disinfectants and antiseptics, along with potential utility and limitations. While not exhaustive, this review’s goal is to add to the body of literature available on this topic and give interventional...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946573/ https://www.ncbi.nlm.nih.gov/pubmed/33693989 http://dx.doi.org/10.1007/s11916-021-00938-3 |
_version_ | 1783663081009709056 |
---|---|
author | Aranke, Mayank Moheimani, Roya Phuphanich, Melissa Kaye, Alan D. Ngo, Anh L. Viswanath, Omar Herman, Jared |
author_facet | Aranke, Mayank Moheimani, Roya Phuphanich, Melissa Kaye, Alan D. Ngo, Anh L. Viswanath, Omar Herman, Jared |
author_sort | Aranke, Mayank |
collection | PubMed |
description | PURPOSE OF REVIEW: This review aims to provide relevant, aggregate information about a variety of disinfectants and antiseptics, along with potential utility and limitations. While not exhaustive, this review’s goal is to add to the body of literature available on this topic and give interventional providers and practitioners an additional resource to consider when performing procedures. RECENT FINDINGS: In the current SARS-CoV2 epidemiological environment, infection control and costs associated with healthcare-associated infections (HAIs) are of paramount importance. Even before the onset of SARS-CoV2, HAIs affected nearly 2million patients a year in the USA and resulted in nearly 90,000 deaths, all of which resulted in a cost to hospitals ranging from US$28 billion to 45 billion. The onset SARS-CoV2, though not spread by an airborne route, has heightened infection control protocols in hospitals and, as such, cast a renewed focus on disinfectants and their utility across different settings and organisms. SUMMARY: The aim of this review is to provide a comprehensive overview of disinfectants used in the inpatient setting. |
format | Online Article Text |
id | pubmed-7946573 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-79465732021-03-11 Disinfectants In Interventional Practices Aranke, Mayank Moheimani, Roya Phuphanich, Melissa Kaye, Alan D. Ngo, Anh L. Viswanath, Omar Herman, Jared Curr Pain Headache Rep Chronic Pain Medicine (O Viswanath, Section Editor) PURPOSE OF REVIEW: This review aims to provide relevant, aggregate information about a variety of disinfectants and antiseptics, along with potential utility and limitations. While not exhaustive, this review’s goal is to add to the body of literature available on this topic and give interventional providers and practitioners an additional resource to consider when performing procedures. RECENT FINDINGS: In the current SARS-CoV2 epidemiological environment, infection control and costs associated with healthcare-associated infections (HAIs) are of paramount importance. Even before the onset of SARS-CoV2, HAIs affected nearly 2million patients a year in the USA and resulted in nearly 90,000 deaths, all of which resulted in a cost to hospitals ranging from US$28 billion to 45 billion. The onset SARS-CoV2, though not spread by an airborne route, has heightened infection control protocols in hospitals and, as such, cast a renewed focus on disinfectants and their utility across different settings and organisms. SUMMARY: The aim of this review is to provide a comprehensive overview of disinfectants used in the inpatient setting. Springer US 2021-03-11 2021 /pmc/articles/PMC7946573/ /pubmed/33693989 http://dx.doi.org/10.1007/s11916-021-00938-3 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Chronic Pain Medicine (O Viswanath, Section Editor) Aranke, Mayank Moheimani, Roya Phuphanich, Melissa Kaye, Alan D. Ngo, Anh L. Viswanath, Omar Herman, Jared Disinfectants In Interventional Practices |
title | Disinfectants In Interventional Practices |
title_full | Disinfectants In Interventional Practices |
title_fullStr | Disinfectants In Interventional Practices |
title_full_unstemmed | Disinfectants In Interventional Practices |
title_short | Disinfectants In Interventional Practices |
title_sort | disinfectants in interventional practices |
topic | Chronic Pain Medicine (O Viswanath, Section Editor) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946573/ https://www.ncbi.nlm.nih.gov/pubmed/33693989 http://dx.doi.org/10.1007/s11916-021-00938-3 |
work_keys_str_mv | AT arankemayank disinfectantsininterventionalpractices AT moheimaniroya disinfectantsininterventionalpractices AT phuphanichmelissa disinfectantsininterventionalpractices AT kayealand disinfectantsininterventionalpractices AT ngoanhl disinfectantsininterventionalpractices AT viswanathomar disinfectantsininterventionalpractices AT hermanjared disinfectantsininterventionalpractices |